Steinhart Richard I - Insider Non-Derivative Transactions at BioXcel Therapeutics, Inc. (BTAI) - (SEC)

Updated on December 12, 2024.

According to recent SEC insider information filed on Sep 16, 2024, Steinhart Richard I's relationship to BioXcel Therapeutics, Inc. (BTAI) is Officer (Chief Financial Officer), and currently has 6,204 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other BTAI insiders.

Data Source: SEC.
Steinhart Richard I - Insider Non-Derivative Transactions of BTAI Common Stock
Steinhart Richard I - Insider Non-Derivative Transactions at BTAI
Items per page:
0 of 0
Date Transaction No. of Shares Price Per Share Shares Owned After Transactions
Sep 17, 2024 Sell -- (Common Stock) 356 0.69 6204
Sep 16, 2024 M -- (Common Stock) 563 0 6560
Sep 15, 2024 M -- (Common Stock) 521 0 5997
Jun 18, 2024 Sell -- (Common Stock) 372 1.26 5476
Jun 16, 2024 M -- (Common Stock) 562 0 5848
Jun 15, 2024 M -- (Common Stock) 521 0 5286
Apr 5, 2024 Sell -- (Common Stock) 1069 2.64 4765
Mar 16, 2024 M -- (Common Stock) 2250 0 5834
Mar 15, 2024 M -- (Common Stock) 521 0 3584
Dec 15, 2023 M -- (Common Stock) 521 0 3063
Sep 15, 2023 M -- (Common Stock) 521 0 2542
Jun 15, 2023 M -- (Common Stock) 521 0 2021
May 16, 2023 Sell -- (Common Stock) 5000 27.17 1500
May 15, 2023 M -- (Common Stock) 5000 0 6500
Mar 16, 2023 Sell -- (Common Stock) 2084 19.5 1500
Mar 15, 2023 M -- (Common Stock) 2084 0 3584